Functional antagonism of chromatin modulators regulates epithelial-mesenchymal transition

Chromatin modulators with antagonistic functions on epithelial-mesenchymal interconversion regulate common pan-cancer genes. Epithelial-mesenchymal transition (EMT) is a developmental process hijacked by cancer cells to modulate proliferation, migration, and stress response. Whereas kinase signaling...

Full description

Saved in:

Bibliographic Details
Published in:	Science advances Vol. 7; no. 9
Main Authors:	Serresi, Michela, Kertalli, Sonia, Li, Lifei, Schmitt, Matthias Jürgen, Dramaretska, Yuliia, Wierikx, Jikke, Hulsman, Danielle, Gargiulo, Gaetano
Format:	Journal Article
Language:	English
Published:	United States American Association for the Advancement of Science 01.02.2021
Subjects:	Biochemistry Cancer SciAdv r-articles
ISSN:	2375-2548, 2375-2548
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Abstract	Chromatin modulators with antagonistic functions on epithelial-mesenchymal interconversion regulate common pan-cancer genes. Epithelial-mesenchymal transition (EMT) is a developmental process hijacked by cancer cells to modulate proliferation, migration, and stress response. Whereas kinase signaling is believed to be an EMT driver, the molecular mechanisms underlying epithelial-mesenchymal interconversion are incompletely understood. Here, we show that the impact of chromatin regulators on EMT interconversion is broader than that of kinases. By combining pharmacological modulation of EMT, synthetic genetic tracing, and CRISPR interference screens, we uncovered a minority of kinases and several chromatin remodelers, writers, and readers governing homeostatic EMT in lung cancer cells. Loss of ARID1A, DOT1L, BRD2, and ZMYND8 had nondeterministic and sometimes opposite consequences on epithelial-mesenchymal interconversion. Together with RNAPII and AP-1, these antagonistic gatekeepers control chromatin of active enhancers, including pan-cancer-EMT signature genes enabling supraclassification of anatomically diverse tumors. Thus, our data uncover general principles underlying transcriptional control of cancer cell plasticity and offer a platform to systematically explore chromatin regulators in tumor-state–specific therapy.
AbstractList	Chromatin modulators with antagonistic functions on epithelial-mesenchymal interconversion regulate common pan-cancer genes. Epithelial-mesenchymal transition (EMT) is a developmental process hijacked by cancer cells to modulate proliferation, migration, and stress response. Whereas kinase signaling is believed to be an EMT driver, the molecular mechanisms underlying epithelial-mesenchymal interconversion are incompletely understood. Here, we show that the impact of chromatin regulators on EMT interconversion is broader than that of kinases. By combining pharmacological modulation of EMT, synthetic genetic tracing, and CRISPR interference screens, we uncovered a minority of kinases and several chromatin remodelers, writers, and readers governing homeostatic EMT in lung cancer cells. Loss of ARID1A, DOT1L, BRD2, and ZMYND8 had nondeterministic and sometimes opposite consequences on epithelial-mesenchymal interconversion. Together with RNAPII and AP-1, these antagonistic gatekeepers control chromatin of active enhancers, including pan-cancer-EMT signature genes enabling supraclassification of anatomically diverse tumors. Thus, our data uncover general principles underlying transcriptional control of cancer cell plasticity and offer a platform to systematically explore chromatin regulators in tumor-state–specific therapy. Epithelial-mesenchymal transition (EMT) is a developmental process hijacked by cancer cells to modulate proliferation, migration, and stress response. Whereas kinase signaling is believed to be an EMT driver, the molecular mechanisms underlying epithelial-mesenchymal interconversion are incompletely understood. Here, we show that the impact of chromatin regulators on EMT interconversion is broader than that of kinases. By combining pharmacological modulation of EMT, synthetic genetic tracing, and CRISPR interference screens, we uncovered a minority of kinases and several chromatin remodelers, writers, and readers governing homeostatic EMT in lung cancer cells. Loss of ARID1A, DOT1L, BRD2, and ZMYND8 had nondeterministic and sometimes opposite consequences on epithelial-mesenchymal interconversion. Together with RNAPII and AP-1, these antagonistic gatekeepers control chromatin of active enhancers, including pan-cancer-EMT signature genes enabling supraclassification of anatomically diverse tumors. Thus, our data uncover general principles underlying transcriptional control of cancer cell plasticity and offer a platform to systematically explore chromatin regulators in tumor-state-specific therapy. Epithelial-mesenchymal transition (EMT) is a developmental process hijacked by cancer cells to modulate proliferation, migration, and stress response. Whereas kinase signaling is believed to be an EMT driver, the molecular mechanisms underlying epithelial-mesenchymal interconversion are incompletely understood. Here, we show that the impact of chromatin regulators on EMT interconversion is broader than that of kinases. By combining pharmacological modulation of EMT, synthetic genetic tracing, and CRISPR interference screens, we uncovered a minority of kinases and several chromatin remodelers, writers, and readers governing homeostatic EMT in lung cancer cells. Loss of ARID1A, DOT1L, BRD2, and ZMYND8 had nondeterministic and sometimes opposite consequences on epithelial-mesenchymal interconversion. Together with RNAPII and AP-1, these antagonistic gatekeepers control chromatin of active enhancers, including pan-cancer-EMT signature genes enabling supraclassification of anatomically diverse tumors. Thus, our data uncover general principles underlying transcriptional control of cancer cell plasticity and offer a platform to systematically explore chromatin regulators in tumor-state-specific therapy.Epithelial-mesenchymal transition (EMT) is a developmental process hijacked by cancer cells to modulate proliferation, migration, and stress response. Whereas kinase signaling is believed to be an EMT driver, the molecular mechanisms underlying epithelial-mesenchymal interconversion are incompletely understood. Here, we show that the impact of chromatin regulators on EMT interconversion is broader than that of kinases. By combining pharmacological modulation of EMT, synthetic genetic tracing, and CRISPR interference screens, we uncovered a minority of kinases and several chromatin remodelers, writers, and readers governing homeostatic EMT in lung cancer cells. Loss of ARID1A, DOT1L, BRD2, and ZMYND8 had nondeterministic and sometimes opposite consequences on epithelial-mesenchymal interconversion. Together with RNAPII and AP-1, these antagonistic gatekeepers control chromatin of active enhancers, including pan-cancer-EMT signature genes enabling supraclassification of anatomically diverse tumors. Thus, our data uncover general principles underlying transcriptional control of cancer cell plasticity and offer a platform to systematically explore chromatin regulators in tumor-state-specific therapy. Chromatin modulators with antagonistic functions on epithelial-mesenchymal interconversion regulate common pan-cancer genes. Epithelial-mesenchymal transition (EMT) is a developmental process hijacked by cancer cells to modulate proliferation, migration, and stress response. Whereas kinase signaling is believed to be an EMT driver, the molecular mechanisms underlying epithelial-mesenchymal interconversion are incompletely understood. Here, we show that the impact of chromatin regulators on EMT interconversion is broader than that of kinases. By combining pharmacological modulation of EMT, synthetic genetic tracing, and CRISPR interference screens, we uncovered a minority of kinases and several chromatin remodelers, writers, and readers governing homeostatic EMT in lung cancer cells. Loss of ARID1A, DOT1L, BRD2, and ZMYND8 had nondeterministic and sometimes opposite consequences on epithelial-mesenchymal interconversion. Together with RNAPII and AP-1, these antagonistic gatekeepers control chromatin of active enhancers, including pan-cancer-EMT signature genes enabling supraclassification of anatomically diverse tumors. Thus, our data uncover general principles underlying transcriptional control of cancer cell plasticity and offer a platform to systematically explore chromatin regulators in tumor-state–specific therapy.
Author	Kertalli, Sonia Gargiulo, Gaetano Li, Lifei Hulsman, Danielle Schmitt, Matthias Jürgen Dramaretska, Yuliia Wierikx, Jikke Serresi, Michela
Author_xml	– sequence: 1 givenname: Michela orcidid: 0000-0001-6839-8658 surname: Serresi fullname: Serresi, Michela organization: Max-Delbrück-Center for Molecular Medicine (MDC), Robert-Rössle-Str. 10, 13092 Berlin, Germany – sequence: 2 givenname: Sonia surname: Kertalli fullname: Kertalli, Sonia organization: Max-Delbrück-Center for Molecular Medicine (MDC), Robert-Rössle-Str. 10, 13092 Berlin, Germany – sequence: 3 givenname: Lifei surname: Li fullname: Li, Lifei organization: Max-Delbrück-Center for Molecular Medicine (MDC), Robert-Rössle-Str. 10, 13092 Berlin, Germany – sequence: 4 givenname: Matthias Jürgen orcidid: 0000-0001-8296-5858 surname: Schmitt fullname: Schmitt, Matthias Jürgen organization: Max-Delbrück-Center for Molecular Medicine (MDC), Robert-Rössle-Str. 10, 13092 Berlin, Germany – sequence: 5 givenname: Yuliia orcidid: 0000-0002-9792-0465 surname: Dramaretska fullname: Dramaretska, Yuliia organization: Max-Delbrück-Center for Molecular Medicine (MDC), Robert-Rössle-Str. 10, 13092 Berlin, Germany – sequence: 6 givenname: Jikke surname: Wierikx fullname: Wierikx, Jikke organization: Max-Delbrück-Center for Molecular Medicine (MDC), Robert-Rössle-Str. 10, 13092 Berlin, Germany – sequence: 7 givenname: Danielle surname: Hulsman fullname: Hulsman, Danielle organization: Division of Molecular Genetics, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam 1066 CX, Netherlands – sequence: 8 givenname: Gaetano orcidid: 0000-0001-5414-4251 surname: Gargiulo fullname: Gargiulo, Gaetano organization: Max-Delbrück-Center for Molecular Medicine (MDC), Robert-Rössle-Str. 10, 13092 Berlin, Germany
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/33627422$$D View this record in MEDLINE/PubMed
BookMark	eNp1kc1P3DAQxa2KCihw7RHl2Eu2_kocX5AqBLQSEpdy4GRNvJNdV4692A4S_z1ZdqmgUk8z0sz7vdG8L-QgxICEfGV0wRhvv2frYPm0gH6ptJKfyDEXqql5I7uDd_0ROcv5D6WUybZtmD4kR0K0XEnOj8nD9RRscTGAryAUWMXg8ljFobLrFEcoLlRjXE4eSky5Srjatpgr3LiyRu_A1yNmDHb9PM6MkiBktwWeks8D-Ixn-3pC7q-vfl_-rG_vbn5d_ritrdC01ErYrtda2o6KHpnQ2CFyEL3oBhx61bQtaNXooeF0kI1QSgxM9VwIUEx2WpyQix13M_UjLi2G-QZvNsmNkJ5NBGc-ToJbm1V8MkpTyVs5A77tASk-TpiLGV226D0EjFM2XGohm068ep2_9_pr8vbPeUHuFmyKOSccjHUFtu-YrZ03jJptcmaXnNknN8sW_8jeyP8RvACDEaCN
CitedBy_id	crossref_primary_10_1088_1478_3975_ac4ee2 crossref_primary_10_1038_s42003_024_06441_w crossref_primary_10_3389_fcell_2021_828250 crossref_primary_10_1038_s41419_024_07011_y crossref_primary_10_1038_s41467_024_45069_6 crossref_primary_10_1038_s41467_025_59503_w crossref_primary_10_7554_eLife_64846 crossref_primary_10_1007_s12038_022_00254_x crossref_primary_10_1158_1078_0432_CCR_22_1896 crossref_primary_10_3390_biom12010029 crossref_primary_10_1038_s41556_024_01438_3 crossref_primary_10_1186_s12943_022_01552_6 crossref_primary_10_1093_neuonc_noaf169 crossref_primary_10_1186_s12964_022_00870_y crossref_primary_10_1007_s12032_022_01801_0 crossref_primary_10_3390_biom12030348 crossref_primary_10_1016_j_molmed_2023_04_005 crossref_primary_10_1016_j_bbcan_2025_189307 crossref_primary_10_1093_neuonc_noab269 crossref_primary_10_52586_4997 crossref_primary_10_3389_fonc_2021_657546 crossref_primary_10_1016_j_lungcan_2025_108594 crossref_primary_10_1088_1478_3975_ac482c crossref_primary_10_7554_eLife_92559_2 crossref_primary_10_3390_cells10123435 crossref_primary_10_1016_j_tranon_2023_101848 crossref_primary_10_1091_mbc_E21_10_0521 crossref_primary_10_1158_2159_8290_CD_21_0282 crossref_primary_10_3389_fgene_2022_864612 crossref_primary_10_1073_pnas_2426714122 crossref_primary_10_7554_eLife_92559 crossref_primary_10_1002_adma_202504363 crossref_primary_10_1038_s41586_022_05202_1 crossref_primary_10_1124_jpet_123_002036 crossref_primary_10_3390_cancers14235746 crossref_primary_10_1186_s12915_022_01407_y crossref_primary_10_3892_mmr_2022_12758 crossref_primary_10_3389_fcell_2023_1295555
Cites_doi	10.1016/j.febslet.2012.02.037 10.1038/s41588-019-0489-5 10.1038/nm.3968 10.1038/nrc.2017.118 10.1038/ng.2936 10.1126/sciadv.aaz3440 10.1016/j.ydbio.2011.12.041 10.1016/j.molcel.2016.06.035 10.1038/s41588-019-0477-9 10.1038/ng.2628 10.1182/blood-2014-10-607309 10.1016/j.cell.2006.02.041 10.1158/2159-8290.CD-20-0219 10.1101/gad.310136.117 10.1016/j.cell.2012.03.026 10.1126/science.aam7304 10.1016/j.molcel.2017.02.027 10.1038/nrc1209 10.1016/j.ccell.2015.12.006 10.1016/j.ccr.2013.03.030 10.1016/j.molcel.2018.08.042 10.1016/j.cell.2010.03.030 10.1016/j.cell.2017.07.005 10.1016/j.celrep.2018.05.097 10.1038/nbt.3536 10.1016/j.celrep.2015.12.100 10.1016/j.cell.2012.12.015 10.1016/j.ccr.2013.04.020 10.1158/0008-5472.CAN-13-2702 10.1016/j.cell.2017.06.010 10.1053/j.gastro.2014.03.052 10.1038/nature16064 10.1016/j.molcel.2011.04.004 10.1038/s41586-019-1897-5 10.1038/nsmb.2434 10.1126/scisignal.aaf8175 10.1016/j.cell.2016.01.009 10.1038/nm.3336 10.1038/bjc.2014.80 10.1016/j.cell.2014.06.004 10.1016/j.cell.2013.06.005 10.1038/nsmb.2449 10.1038/nature21064 10.1084/jem.20180801 10.1016/j.ccr.2013.08.005 10.1016/j.cell.2018.03.022 10.1038/ng1972 10.1038/nprot.2014.185
ContentType	Journal Article
Copyright	Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). 2021 The Authors
Copyright_xml	– notice: Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). – notice: Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). 2021 The Authors
DBID	AAYXX CITATION NPM 7X8 5PM
DOI	10.1126/sciadv.abd7974
DatabaseName	CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles)
DatabaseTitle	CrossRef PubMed MEDLINE - Academic
DatabaseTitleList	PubMed MEDLINE - Academic CrossRef
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Sciences (General)
EISSN	2375-2548
ExternalDocumentID	PMC7904264 33627422 10_1126_sciadv_abd7974
Genre	Research Support, Non-U.S. Gov't Journal Article
GrantInformation_xml	– fundername: European Research Council grantid: 714922 – fundername: ; grantid: NKI-2014-7208 – fundername: ; grantid: VH-NG-1153 – fundername: ; grantid: 714922 – fundername: ; grantid: DFG SE 2847/2-1
GroupedDBID	53G 5VS AAFWJ AAYXX ACGFS ADAXU ADBBV ADPDF AENVI AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BCGUY BCNDV BKF CITATION EBS FRP GROUPED_DOAJ GX1 HYE KQ8 M48 M~E OK1 OVD OVEED RHI RPM TEORI ADRAZ EJD NPM 7X8 5PM
ID	FETCH-LOGICAL-c390t-73c8b994c803be139e8ee2a3b38fefb7566a9759f520f453773f17b233a714893
ISICitedReferencesCount	43
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000622481300018&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	2375-2548
IngestDate	Tue Sep 30 16:36:07 EDT 2025 Fri Jul 11 07:37:12 EDT 2025 Mon Jul 21 05:35:47 EDT 2025 Sat Nov 29 06:00:26 EST 2025 Tue Nov 18 22:24:08 EST 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	9
Language	English
License	https://creativecommons.org/licenses/by-nc/4.0 Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license, which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited.
LinkModel	OpenURL
MergedId	FETCHMERGED-LOGICAL-c390t-73c8b994c803be139e8ee2a3b38fefb7566a9759f520f453773f17b233a714893
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 These authors contributed equally to this work.
ORCID	0000-0002-9792-0465 0000-0001-5414-4251 0000-0001-8296-5858 0000-0001-6839-8658
OpenAccessLink	http://dx.doi.org/10.1126/sciadv.abd7974
PMID	33627422
PQID	2493458389
PQPubID	23479
ParticipantIDs	pubmedcentral_primary_oai_pubmedcentral_nih_gov_7904264 proquest_miscellaneous_2493458389 pubmed_primary_33627422 crossref_citationtrail_10_1126_sciadv_abd7974 crossref_primary_10_1126_sciadv_abd7974
PublicationCentury	2000
PublicationDate	2021-02-01
PublicationDateYYYYMMDD	2021-02-01
PublicationDate_xml	– month: 02 year: 2021 text: 2021-02-01 day: 01
PublicationDecade	2020
PublicationPlace	United States
PublicationPlace_xml	– name: United States
PublicationTitle	Science advances
PublicationTitleAlternate	Sci Adv
PublicationYear	2021
Publisher	American Association for the Advancement of Science
Publisher_xml	– name: American Association for the Advancement of Science
References	e_1_3_2_26_2 e_1_3_2_49_2 e_1_3_2_28_2 e_1_3_2_20_2 e_1_3_2_43_2 e_1_3_2_22_2 e_1_3_2_45_2 e_1_3_2_24_2 e_1_3_2_47_2 e_1_3_2_9_2 e_1_3_2_16_2 e_1_3_2_37_2 e_1_3_2_7_2 e_1_3_2_18_2 e_1_3_2_39_2 e_1_3_2_10_2 e_1_3_2_31_2 e_1_3_2_5_2 e_1_3_2_12_2 e_1_3_2_33_2 e_1_3_2_3_2 e_1_3_2_14_2 e_1_3_2_35_2 e_1_3_2_50_2 e_1_3_2_27_2 e_1_3_2_48_2 e_1_3_2_29_2 e_1_3_2_40_2 e_1_3_2_21_2 e_1_3_2_42_2 e_1_3_2_23_2 e_1_3_2_44_2 e_1_3_2_25_2 e_1_3_2_46_2 e_1_3_2_15_2 e_1_3_2_38_2 e_1_3_2_8_2 e_1_3_2_17_2 e_1_3_2_6_2 e_1_3_2_19_2 e_1_3_2_30_2 e_1_3_2_32_2 e_1_3_2_11_2 e_1_3_2_34_2 e_1_3_2_4_2 e_1_3_2_13_2 e_1_3_2_36_2 e_1_3_2_2_2 Douillet D. (e_1_3_2_41_2) 2020; 128
References_xml	– ident: e_1_3_2_7_2 doi: 10.1016/j.febslet.2012.02.037 – ident: e_1_3_2_11_2 doi: 10.1038/s41588-019-0489-5 – ident: e_1_3_2_44_2 doi: 10.1038/nm.3968 – ident: e_1_3_2_15_2 doi: 10.1038/nrc.2017.118 – ident: e_1_3_2_36_2 doi: 10.1038/ng.2936 – ident: e_1_3_2_43_2 doi: 10.1126/sciadv.aaz3440 – ident: e_1_3_2_2_2 doi: 10.1016/j.ydbio.2011.12.041 – ident: e_1_3_2_38_2 doi: 10.1016/j.molcel.2016.06.035 – ident: e_1_3_2_46_2 doi: 10.1038/s41588-019-0477-9 – ident: e_1_3_2_20_2 doi: 10.1038/ng.2628 – ident: e_1_3_2_37_2 doi: 10.1182/blood-2014-10-607309 – ident: e_1_3_2_16_2 doi: 10.1016/j.cell.2006.02.041 – ident: e_1_3_2_24_2 doi: 10.1158/2159-8290.CD-20-0219 – ident: e_1_3_2_50_2 doi: 10.1101/gad.310136.117 – ident: e_1_3_2_18_2 doi: 10.1016/j.cell.2012.03.026 – ident: e_1_3_2_21_2 doi: 10.1126/science.aam7304 – ident: e_1_3_2_30_2 doi: 10.1016/j.molcel.2017.02.027 – ident: e_1_3_2_33_2 doi: 10.1038/nrc1209 – ident: e_1_3_2_13_2 doi: 10.1016/j.ccell.2015.12.006 – ident: e_1_3_2_34_2 doi: 10.1016/j.ccr.2013.03.030 – ident: e_1_3_2_39_2 doi: 10.1016/j.molcel.2018.08.042 – ident: e_1_3_2_49_2 doi: 10.1016/j.cell.2010.03.030 – ident: e_1_3_2_45_2 doi: 10.1016/j.cell.2017.07.005 – ident: e_1_3_2_32_2 doi: 10.1016/j.celrep.2018.05.097 – ident: e_1_3_2_35_2 doi: 10.1038/nbt.3536 – ident: e_1_3_2_40_2 doi: 10.1016/j.celrep.2015.12.100 – ident: e_1_3_2_17_2 doi: 10.1016/j.cell.2012.12.015 – ident: e_1_3_2_22_2 doi: 10.1016/j.ccr.2013.04.020 – ident: e_1_3_2_28_2 doi: 10.1158/0008-5472.CAN-13-2702 – ident: e_1_3_2_29_2 doi: 10.1016/j.cell.2017.06.010 – ident: e_1_3_2_42_2 doi: 10.1053/j.gastro.2014.03.052 – ident: e_1_3_2_4_2 doi: 10.1038/nature16064 – ident: e_1_3_2_27_2 doi: 10.1016/j.molcel.2011.04.004 – ident: e_1_3_2_12_2 doi: 10.1038/s41586-019-1897-5 – ident: e_1_3_2_25_2 doi: 10.1038/nsmb.2434 – ident: e_1_3_2_10_2 doi: 10.1126/scisignal.aaf8175 – ident: e_1_3_2_6_2 doi: 10.1016/j.cell.2016.01.009 – ident: e_1_3_2_3_2 doi: 10.1038/nm.3336 – ident: e_1_3_2_8_2 doi: 10.1038/bjc.2014.80 – ident: e_1_3_2_14_2 doi: 10.1016/j.cell.2014.06.004 – ident: e_1_3_2_19_2 doi: 10.1016/j.cell.2013.06.005 – ident: e_1_3_2_26_2 doi: 10.1038/nsmb.2449 – ident: e_1_3_2_5_2 doi: 10.1038/nature21064 – volume: 128 start-page: 693 year: 2020 ident: e_1_3_2_41_2 article-title: Uncoupling histone H3K4 trimethylation from developmental gene expression via an equilibrium of COMPASS, Polycomb and DNA methylation publication-title: Nat. Genet. – ident: e_1_3_2_23_2 doi: 10.1084/jem.20180801 – ident: e_1_3_2_9_2 doi: 10.1016/j.ccr.2013.08.005 – ident: e_1_3_2_31_2 doi: 10.1016/j.cell.2018.03.022 – ident: e_1_3_2_47_2 doi: 10.1038/ng1972 – ident: e_1_3_2_48_2 doi: 10.1038/nprot.2014.185
SSID	ssj0001466519
Score	2.3573766
Snippet	Chromatin modulators with antagonistic functions on epithelial-mesenchymal interconversion regulate common pan-cancer genes. Epithelial-mesenchymal transition... Epithelial-mesenchymal transition (EMT) is a developmental process hijacked by cancer cells to modulate proliferation, migration, and stress response. Whereas... Chromatin modulators with antagonistic functions on epithelial-mesenchymal interconversion regulate common pan-cancer genes. Epithelial-mesenchymal transition...
SourceID	pubmedcentral proquest pubmed crossref
SourceType	Open Access Repository Aggregation Database Index Database Enrichment Source
SubjectTerms	Biochemistry Cancer SciAdv r-articles
Title	Functional antagonism of chromatin modulators regulates epithelial-mesenchymal transition
URI	https://www.ncbi.nlm.nih.gov/pubmed/33627422 https://www.proquest.com/docview/2493458389 https://pubmed.ncbi.nlm.nih.gov/PMC7904264
Volume	7
WOSCitedRecordID	wos000622481300018&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2375-2548 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001466519 issn: 2375-2548 databaseCode: DOA dateStart: 20150101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2375-2548 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001466519 issn: 2375-2548 databaseCode: M~E dateStart: 20150101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Jj9MwFLaYgQMXxLCWpTISYtHIo9ROYvsIo6kQKgWJjlROkZPaNFKblqaDhgu_nWfHWQpFGg5cospxE8fv5eXtH0LPIwVKqBEBoWk6I2EcGqJAChKutbBhThnEyoFN8PFYTKfyk_fplg5OgBeFuLyU6_9KahgDYtvS2X8gd3NRGIDfQHQ4AtnheCXCD-FL5R18sGvqK7y05dJlj883K6ufFhb-xqJ2WZydTYVFr8tjvbblGQtYIFnakqRs_mPpMtHhY5Y35PN6bC0SfApBo5iD6AH7Pa8T8vVCtRLd6vlVMfZnWFNzYlTVZ-dG521UaL70USuHR56r8vi9Dem_PbW1ol1PBR3Uyc21QKOMRwQM0kre6j1jXiLzDuPJ_XK-RqaExzxR6YzLCutnt6H2-GMyPB-NksnZdPJi_Y1YrDEbk_fAKwfoOuWRtLLww8-OZy6M48ghwjSL890-fbVV55672swfJsrvmbYd1WVyG93yNgd-U_HKEbqmizvoyJOwxK986_HXd9GXlnlwyzx4ZXDDPLhlHtwwD97PPLhlnnvofHg2OX1HPPgGyZgMtoSzTKRShpkIWKrBTtBCa6pYyoTRJuVgBigJu2ciGpgwYpwzM-ApZUzxge1odB8dFqtCP0Q45DHnM5axTKlQMCEM_ElKboRhJlZBD5F6E5PMd6a3ACmLxFmoNE6qTU_8pvfQy2b-uurJ8teZz2qaJCA2bSxMFXp1USY0lMylDMgeelDRqLkWYxaQitIe4jvUaybYluy7Z4p87lqzc2l9EuGjK9z3MbrZviRP0OF2c6GfohvZ921ebvrogE9F33mI-o49fwE2_LaT
linkProvider	ISSN International Centre
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Functional+antagonism+of+chromatin+modulators+regulates+epithelial-mesenchymal+transition&rft.jtitle=Science+advances&rft.au=Serresi%2C+Michela&rft.au=Kertalli%2C+Sonia&rft.au=Li%2C+Lifei&rft.au=Schmitt%2C+Matthias+J%C3%BCrgen&rft.date=2021-02-01&rft.issn=2375-2548&rft.eissn=2375-2548&rft.volume=7&rft.issue=9&rft_id=info:doi/10.1126%2Fsciadv.abd7974&rft.externalDBID=NO_FULL_TEXT
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2375-2548&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2375-2548&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2375-2548&client=summon